Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study

• Sadanori Okada,

  Affiliations Department of Diabetology, Nara Medical University, Kashihara, Nara, Japan, First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan

  ⨯
• Takeshi Morimoto,

  Affiliation Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

  ⨯
• Hisao Ogawa,

  Affiliation Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan

  ⨯
• Mio Sakuma,

  Affiliation Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan

  ⨯
• Hirofumi Soejima,

  Affiliation Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan

  ⨯
• Masafumi Nakayama,

  Affiliation Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan

  ⨯
• Hideaki Jinnouchi,

  Affiliation Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan

  ⨯
• Masako Waki,

  Affiliation Division of Endocrinology and Metabolism, Department of Internal Medicine, Shizuoka City Hospital, Shizuoka, Japan

  ⨯
• Yasuhiro Akai,

  Affiliation Department of Diabetology, Nara Medical University, Kashihara, Nara, Japan

  ⨯
• Hitoshi Ishii,

  Affiliation Department of Diabetology, Nara Medical University, Kashihara, Nara, Japan

  ⨯
• Yoshihiko Saito ,

  * E-mail: yssaito@naramed-u.ac.jp

  Affiliations First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan, Department of Regulatory Medicine of Blood Pressure, Nara Medical University, Kashihara, Nara, Japan

  ⨯
• investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial

  ¶Membership of the JPAD trial is listed in the Acknowledgments.

  ⨯